LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

The highly competitive thermoplastic industry is constantly expanding its capacities and developing new products. Additionally, resin manufacturers periodically institute formulation changes due to ...

For decades commercial and academic scientists have sought reliable serum-free media. As far back as the 1960s a number of options were available for the cultivation of some cell lines. Now, after ...

BETHLEHEM, Pa., Jan. 8, 2013 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Deepak Tiwari, PhD to the position of Director, Formulation and Process Development. Dr. Tiwari, ...

This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of ...

BEND, Ore., Oct. 18 /PRNewswire/ -- Bend Research Inc. (www.bendres.com), a leading independent technology-based drug-formulation development and manufacturing organization, announced today it has ...

This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of ...